LOX-1, a possible clue to the missing link between hypertension and atherogenesis

被引：40

作者：

Kita, T ^{[1
]}

机构：

[1] Kyoto Univ, Grad Sch Med, Dept Geriatr Med, Sakyo Ku, Kyoto 6068507, Japan

来源：

CIRCULATION RESEARCH | 1999年 / 84卷 / 09期

关键词：

angiotensin II; oxidized LDL; LOX-1; endothelial cell; atherosclerosis;

D O I：

10.1161/01.RES.84.9.1113

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1113 / 1115

页数：3

共 45 条

[1] EFFECTS OF CAPTOPRIL ON ATHEROSCLEROSIS IN CYNOMOLGUS MONKEYS [J].

ABERG, G ;

FERRER, P .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 :S65-S72

[2] ASSOCIATION OF THE RENIN SODIUM PROFILE WITH THE RISK OF MYOCARDIAL-INFARCTION IN PATIENTS WITH HYPERTENSION [J].

ALDERMAN, MH ;

MADHAVAN, S ;

OOI, WL ;

COHEN, H ;

SEALEY, JE ;

LARAGH, JH .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (16) :1098-1104

[3] Structure and chromosomal assignment of the human lectin-like oxidized low-density-lipoprotein receptor-1 (LOX-1) gene [J].

Aoyama, T ;

Sawamura, T ;

Furutani, Y ;

Matsuoka, R ;

Yoshida, MC ;

Fujiwara, H ;

Masaki, T .

BIOCHEMICAL JOURNAL, 1999, 339 :177-184

[4] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].

BROWN, MS ;

GOLDSTEIN, JL .

SCIENCE, 1986, 232 (4746) :34-47

[5] DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].

CAMBIEN, F ;

POIRIER, O ;

LECERF, L ;

EVANS, A ;

CAMBOU, JP ;

ARVEILER, D ;

LUC, G ;

BARD, JM ;

BARA, L ;

RICARD, S ;

TIRET, L ;

AMOUYEL, P ;

ALHENCGELAS, F ;

SOUBRIER, F .

NATURE, 1992, 359 (6396) :641-644

[6]

CAPERS QI, 1997, HYPERTENSION, V80, P1397

[7]

Chen XL, 1998, CIRC RES, V83, P952

[8] TRANDOLAPRIL INHIBITS ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J].

CHOBANIAN, AV ;

HAUDENSCHILD, CC ;

NICKERSON, C ;

HOPE, S .

HYPERTENSION, 1992, 20 (04) :473-477

[9] VASCULAR BIOLOGY AND MEDICINE IN THE 1990S-SCOPE, CONCEPTS, POTENTIALS, AND PERSPECTIVES [J].

DZAU, VJ ;

GIBBONS, GH ;

COOKE, JP ;

OMOIGUI, N .

CIRCULATION, 1993, 87 (03) :705-719

[10] Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model - A comparative study with captopril [J].

Furukawa, Y ;

Matsumori, A ;

Hirozane, T ;

Sasayama, S .

CIRCULATION, 1996, 93 (02) :333-339

← 1 2 3 4 5 →